PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.81%
Net income growth above 1.5x AVGO's 6.02%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-15.81%
Both reduce yoy D&A, with AVGO at -0.13%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-133.33%
Negative yoy deferred tax while AVGO stands at 89.22%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-129.19%
Both reduce yoy usage, with AVGO at -336.17%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
22.58%
AR growth while AVGO is negative at -16.23%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-261.54%
Negative yoy inventory while AVGO is 12.18%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-254.29%
Both negative yoy AP, with AVGO at -35.26%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-49.25%
Both reduce yoy usage, with AVGO at -814.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
40.00%
Some yoy increase while AVGO is negative at -52.78%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-2.92%
Negative yoy CFO while AVGO is 0.00%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-163.79%
Negative yoy CapEx while AVGO is 23.48%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-86.01%
Negative yoy acquisition while AVGO stands at 662.50%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-118.37%
Both yoy lines negative, with AVGO at -100.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
105.93%
Proceeds from sales/maturities above 1.5x AVGO's 52.24%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
94.86%
We have some outflow growth while AVGO is negative at -1000.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-152.15%
We reduce yoy invests while AVGO stands at 206.38%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
63.21%
Debt repayment growth of 63.21% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-30.67%
Negative yoy issuance while AVGO is 714.29%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-2.16%
We cut yoy buybacks while AVGO is 23.34%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.